Basel Medical Group Ltd Ordinary Shares (BMGL) Key Ratios
$4.58
$0.00 (0.00%)As on 11-Sep-2026 09:30EDT
Market cap
$7 Mln
Revenue (TTM)
$-- Mln
P/E Ratio
--
P/B Ratio
1.4
Div. Yield
0 %
Key Ratios and Highlights
| Growth Score (%) | Quarterly | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | QoQ | YoY | 1-Year | 3-Years | 5-Years |
| Revenue | -- | -- | 12.63 | 2.03 | -- |
| EBIT | -- | -- | -576.66 | -265.63 | -- |
| Net Profit | -- | -- | -683.15 | -282.83 | -- |
| EPS | -- | -- | -- | -- | -- |
| Book Value | -- | -- | -- | -- | -- |
| Key Ratios (%) | Average | Annual (TTM) | |||
|---|---|---|---|---|---|
| Particulars | 3-Years | 5-Years | Jun-25 | Jun-24 | Jun-23 |
| EBIT-Margin
| -19.52 | -- | -108.67 | 25.68 | 24.43 |
| Net Margin
| -- | -- | -- | -- | -- |
| Return on equity
| -41.35 | -- | -194.61 | 31.77 | 38.79 |
| Return on Capital
| -29.92 | -- | -120.08 | 16.88 | 13.43 |
| Return on Assets
| -16.25 | -- | -72.90 | 13.08 | 11.07 |
| Debt to Equity (x)
| -- | -- | 0.70 | 0.57 | 1.31 |
Profitability
ROCE
-120.08
--
Earning before interest and taxes / (Average net worth + Average total Debt) * 100
|
Company Name
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
Jun-21
|
|---|---|---|---|---|---|
|
Basel Medical Group Ltd Ordinary Shares (BMGL)
|
-120.08
|
16.88
|
13.43
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROE
-194.61
--
Profit after tax / Average Net worth * 100
|
Company Name
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
Jun-21
|
|---|---|---|---|---|---|
|
Basel Medical Group Ltd Ordinary Shares (BMGL)
|
-194.61
|
31.77
|
38.79
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
ROA
-72.90
--
Profit after tax / Average Total assets * 100
|
Company Name
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
Jun-21
|
|---|---|---|---|---|---|
|
Basel Medical Group Ltd Ordinary Shares (BMGL)
|
-72.90
|
13.08
|
11.07
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Margin
-108.67
--
Operating profit (EBIT) / Net Sales * 100
|
Company Name
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
Jun-21
|
|---|---|---|---|---|---|
|
Basel Medical Group Ltd Ordinary Shares (BMGL)
|
-108.67
|
25.68
|
24.43
|
25.40
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Margin
-106.78
--
Net profit / Total Income (Net sales plus other income) * 100
|
Company Name
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
Jun-21
|
|---|---|---|---|---|---|
|
Basel Medical Group Ltd Ordinary Shares (BMGL)
|
-106.78
|
20.62
|
18.38
|
18.56
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Revenue Growth
0.13
--
Year on year growth in net sales
|
Company Name
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
Jun-21
|
|---|---|---|---|---|---|
|
Basel Medical Group Ltd Ordinary Shares (BMGL)
|
0.13
|
0.04
|
-0.09
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
EBIT Growth
-576.66
--
Year on year growth in operating profit (EBIT)
|
Company Name
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
Jun-21
|
|---|---|---|---|---|---|
|
Basel Medical Group Ltd Ordinary Shares (BMGL)
|
-576.66
|
8.89
|
-12.45
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Net Profit Growth
-683.15
--
Year on year growth in profit after tax
|
Company Name
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
Jun-21
|
|---|---|---|---|---|---|
|
Basel Medical Group Ltd Ordinary Shares (BMGL)
|
-683.15
|
16.23
|
-9.84
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Solvency
Debt to Equity
0.70
--
Total debt / Net worth
|
Company Name
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
Jun-21
|
|---|---|---|---|---|---|
|
Basel Medical Group Ltd Ordinary Shares (BMGL)
|
0.70
|
0.57
|
1.31
|
2.74
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Short term debt to equity ratio
0.44
--
(Short term borrowings / Net worth)
|
Company Name
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
Jun-21
|
|---|---|---|---|---|---|
|
Basel Medical Group Ltd Ordinary Shares (BMGL)
|
0.44
|
0.36
|
0.69
|
1.13
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Current Ratio
1.23
--
Current Assets / Current Liabilities and Provisions
|
Company Name
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
Jun-21
|
|---|---|---|---|---|---|
|
Basel Medical Group Ltd Ordinary Shares (BMGL)
|
1.23
|
2.26
|
2.28
|
2.18
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Quick Ratio
1.19
--
(Current Assets - Inventory) / Current Liabilities and Provisions
|
Company Name
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
Jun-21
|
|---|---|---|---|---|---|
|
Basel Medical Group Ltd Ordinary Shares (BMGL)
|
1.19
|
2.25
|
2.27
|
2.17
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Interest Coverage
-60.32
--
Earning before interest and taxes (EBIT) / Interest Expenses
|
Company Name
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
Jun-21
|
|---|---|---|---|---|---|
|
Basel Medical Group Ltd Ordinary Shares (BMGL)
|
-60.32
|
14.64
|
9.93
|
8.44
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Operating Efficiency
Debtors to sales
22.04
--
Debtors outstanding / Net Sales * 100
|
Company Name
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
Jun-21
|
|---|---|---|---|---|---|
|
Basel Medical Group Ltd Ordinary Shares (BMGL)
|
22.04
|
123.81
|
137.38
|
130.26
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Asset Turnover
0.68
--
Sales / Average Total Assets
|
Company Name
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
Jun-21
|
|---|---|---|---|---|---|
|
Basel Medical Group Ltd Ordinary Shares (BMGL)
|
0.68
|
0.63
|
0.60
|
--
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Receivable days
241.01
--
Average Debtors / Sales * 365
|
Company Name
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
Jun-21
|
|---|---|---|---|---|---|
|
Basel Medical Group Ltd Ordinary Shares (BMGL)
|
241.01
|
468.28
|
512.24
|
475.78
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Inventory Days
32.41
--
Average Inventory / Sales * 365
|
Company Name
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
Jun-21
|
|---|---|---|---|---|---|
|
Basel Medical Group Ltd Ordinary Shares (BMGL)
|
32.41
|
13.54
|
12.85
|
11.71
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Payable days
211.58
--
Average Creditors / Cost of goods sold * 365
|
Company Name
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
Jun-21
|
|---|---|---|---|---|---|
|
Basel Medical Group Ltd Ordinary Shares (BMGL)
|
211.58
|
186.32
|
198.75
|
180.88
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|
Cash Conversion Cycle
61.84
--
Receivable Days + Inventory Days - Payable Days
|
Company Name
|
Jun-25
|
Jun-24
|
Jun-23
|
Jun-22
|
Jun-21
|
|---|---|---|---|---|---|
|
Basel Medical Group Ltd Ordinary Shares (BMGL)
|
61.84
|
295.50
|
326.34
|
306.61
|
--
|
|
Peer Median
|
--
|
--
|
--
|
--
|
--
|